GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2021

Top Holdings65 positions

Checking export access…
Activity:

TENET HEALTHCARE CORPORATION

10.6M$713.1M11.8%$17.82+276.00%
11 qtrssince 2018-Q4
Decreased
0

Valeant Pharmaceuticals Intern

16.3M$479M7.9%$22.53+29.62%
11 qtrssince 2018-Q4
Increased
64

Halfmoon Parent Inc

1.3M$304.5M5.0%$177.51+21.13%
11 qtrssince 2018-Q4
Decreased
0

McKesson Corp

1.5M$283.4M4.7%$134.99+38.56%
11 qtrssince 2018-Q4
Decreased
0

DXC Technology Co

7.2M$280.9M4.6%$47.55-18.10%
11 qtrssince 2018-Q4
Decreased
0
PARAPARADelisted

CBS Corp

4.4M$197.5M3.3%——
7 qtrssince 2019-Q4
Increased
90

AmerisourceBergen Corp

1.7M$196.8M3.3%$91.34+16.72%
11 qtrssince 2018-Q4
Decreased
0

Global Payments Inc

926,966$173.8M2.9%$182.61-2.45%
3 qtrssince 2020-Q4
Increased
84
TAKTAK
ADR

TAKEDA PHARMACEUTICAL CO-SPON ADR

9.1M$153.4M2.5%$18.73-15.85%
10 qtrssince 2019-Q1
Decreased
0

Universal Health Services Inc

1M$147.8M2.4%$115.43+23.75%
11 qtrssince 2018-Q4
Decreased
0

Centene Corp

2M$147.4M2.4%$72.930.00%
1 qtr
New
78

HCA Healthcare Inc

666,935$137.9M2.3%$119.49+65.80%
11 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

55,744$136.1M2.3%$92.93+30.59%
11 qtrssince 2018-Q4
Decreased
0

Coca-Cola European Partners PL

2.3M$135.6M2.2%$46.79+7.51%
2 qtrssince 2021-Q1
Increased
76

Walgreens Boots Alliance Inc

2.3M$120.9M2.0%——
2 qtrssince 2021-Q1
Increased
72

Brookdale Senior Living Inc

14.7M$116.2M1.9%$6.13+34.15%
11 qtrssince 2018-Q4
Decreased
0

Facebook Inc

294,114$102.3M1.7%$291.32+18.22%
3 qtrssince 2020-Q4
Decreased
0

Boston Scientific Corp

2.3M$99.3M1.6%$35.28+21.19%
6 qtrssince 2020-Q1
Decreased
0

Corteva Inc

2.2M$98.9M1.6%$32.83+28.37%
7 qtrssince 2019-Q4
Increased
67

DowDuPont Inc

1.2M$96.3M1.6%$86.49+2.05%
3 qtrssince 2020-Q4
Increased
74
$6B
AUM
65
Positions
Q2 2021
Filing
HI score · 3.0/5
Quarterly 13F Value Change
-68%Q1'20$3.7B-2%Q2'20$3.6B-12%Q3'20$3.2B+34%Q4'20$4.3B+38%Q1'21$5.9B+2%Q2'21$6B
Activity profile
$ moved · Q2'21
New23%Increased30%Decreased29%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q20%1-4Q25%1-2Y17%2Y+38%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $6B across 65 positions as of Q2 2021. Top holdings: THC (11.8%), BHC (7.9%), CI (5.0%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q2 2021 Summary

Active quarter - 16 new positions, 14 exits, 21 increased. Top move: PARA (INCREASED, conviction 90). Portfolio: $6.0B across 65 positions.

Top holdings by portfolio weight

Total AUM$6B
THC11.80%
BHC7.92%
CI5.04%
MCK4.69%
DXC4.65%
PARA3.27%
COR3.26%
GPN2.88%
TAK2.54%
UHS2.44%
Other2.44%

Portfolio allocation by GICS sector

Sectors9
Healthcare59.37%
Unknown11.17%
Technology6.83%
Basic Materials6.31%
Industrials6.21%
Communication Services3.96%
Consumer Cyclical3.07%
Consumer Defensive2.25%
Financial Services0.83%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L67
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PMTS INC
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAmazon.com, Inc.
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used